Loading...
Indian Pharmaceutical Exporter · #5 for Levofloxacin · $1.3M export value · DGFT Verified
Medcell Pharma is the #5 Indian exporter of Levofloxacin with $1.3M in export value and 26 verified shipments. Medcell Pharma holds a 1.8% market share in Levofloxacin exports across 5 countries. The company exports 6 pharmaceutical products worth $7.5M across 4 therapeutic categories.
| $2.0K |
| 1 |
| 0.7% |
Medcell Pharma exports Levofloxacin to 5 countries. The largest destination is TURKEY accounting for 53.7% of Medcell Pharma's Levofloxacin shipments, followed by IRAQ (27.0%) and AFGHANISTAN (14.9%). These destinations reflect Medcell Pharma's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SEA GOLD PHARMA | TURKEY | $121.0K | 3 |
| NABAA AL-WARKA SCIENTIFIC BUREAU5 | IRAQ | $20.5K | 1 |
| NABAA AL-WARKA SCIENTIFIC BUREAU | IRAQ | $20.5K | 1 |
| IMS LOJISTIK U/A TASIMACILIK ITH | TURKEY | $20.4K | 2 |
| IMS LOJISTIK ULUSLARARASI YALINAYAK MAHALLESI | IRAQ | $15.5K | 1 |
| AL-SAHA BAGHDAD | IRAQ | $12.1K | 1 |
| BORADARAN MAYAR LTD. | AFGHANISTAN | $11.9K | 2 |
| VANCOUVER SHIPPING & CUSTOMS | UNITED ARAB EMIRATES | $10.5K | 3 |
| ZIA UDDUIN SHARIF LIMITED | AFGHANISTAN | $10.3K | 3 |
| MILAD MUSAWAR TRADE COMPANY | AFGHANISTAN | $8.3K | 2 |
Medcell Pharma supplies Levofloxacin to 16 buyers globally. The largest buyer is SEA GOLD PHARMA (TURKEY), followed by NABAA AL-WARKA SCIENTIFIC BUREAU5 (IRAQ) and NABAA AL-WARKA SCIENTIFIC BUREAU (IRAQ). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $36.0M worth of Levofloxacin through 6,304 shipments from 699 suppliers to 150 countries, serving 1,543 buyers globally. Medcell Pharma contributes $1.3M to this total, accounting for 1.8% of India's Levofloxacin exports. Medcell Pharma ships Levofloxacin to 5 countries through 16 buyers.
Medcell Pharma's average Levofloxacin shipment value is $50.0K per consignment, based on 26 shipments totaling $1.3M. The largest destination is TURKEY (53.7% of Medcell Pharma's Levofloxacin exports).
Medcell Pharma ranks #5 among 699 Indian Levofloxacin exporters with a 1.8% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($9.5M), MICRO LABS LIMITED ($5.0M), SENTISS PHARMA PRIVATE LIMITED ($4.7M). Medcell Pharma processed 26 shipments to 5 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LEVORID(LEVOFLOXACIN TABLETS USP 500MG)E | $121.0K | 3 |
| LEVORID (LEVOFLOXACIN TABLETS USP 500MG)COMPOSITION: EACH FILM COATED TABLET CONTAINS:BATCH NO:ET23102, | $20.5K | 1 |
| LEVORID LEVOFLOXACIN TABLETS USP 500MGCOMPOSITION: EACH FILM COATED TABLET CONTAINS:BATCH NO:ET23102 | $20.5K | 1 |
| LEVORID LEVOFLOXACIN TABLETS USP 500MGCOM:EACH FILM COATED TABLET CON:LEVOFLOXACIN HEMIHYDRATE USPEQ.O/D AS PER INV&PL | $15.5K | 1 |
| PHARMACEUTICAL MEDICINES : LEVOMED (LEVOFLOXACIN TABLETS USP 500MG) LEVOFLOXACINHEMIHYDRATE USP EQUIVALENT | $12.1K | 1 |
| LEVOFIC (LEVOFLOXACIN TABLETS USP 500MG | $11.1K | 1 |
| LEVORUX (LEVOFLOXACIN TABLETS USP 500MG)B. NO.- ET23101, MFG.: 09/2023, EXP.: 08/2026 (PACK SIZE: 1X7 TABLETS) | $10.5K | 3 |
| LEVOKER (LEVOFLOXACIN TABLETS USP 500MG | $9.3K | 1 |
| LEVOSIS (LEVOFLOXACIN TABLETS USP 500MG)COMPOSITION: EACH FILM COATED TABLET CONTAINS LEVOFLOXACIN -O/D AS PER INV&PL | $8.3K | 2 |
| LEVOCELL-500(LEVOFLOXACIN TABLETS USP 500MG)COM:EACH FILM COATED TABLET CON:LEVOFLOXACIN HEMIHYDRATE.O/D AS PER INV&PL | $8.0K | 3 |
Medcell Pharma exports 20 distinct Levofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LEVORID(LEVOFLOXACIN TABLETS USP 500MG)E with 3 shipments worth $121.0K.
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | MACLEODS PHARMACEUTICALS LIMITED | $1.5M | 62 | 19 | $24.3K |
| 11 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED | $1.3M | 27 | 4 | $48.4K |
| 5 | MEDCELL PHARMA ★ | $1.3M | 26 | 5 | $50.0K |
| 12 | AJANTA PHARMA LIMITED | $1.3M | 81 | 15 | $16.0K |
| 10 | CIPLA LIMITED | $1.3M | 25 | 3 | $50.0K |
Medcell Pharma ranks #5 among 699 Indian Levofloxacin exporters. Average shipment value of $50.0K compared to the market average of $51.5K. The closest competitors by value are MACLEODS PHARMACEUTICALS LIMITED and COMBITIC GLOBAL CAPLET PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 670 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 633 | 10.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 620 | 9.8% |
| DELHI AIR | 531 | 8.4% |
| NHAVA SHEVA SEA (INNSA1) | 439 | 7.0% |
| JNPT/ NHAVA SHEVA SEA | 240 | 3.8% |
| JNPT | 186 | 3.0% |
| Bombay Air | 164 | 2.6% |
Visual overview of India's levofloxacin supplier profile for Medcell Pharma — top suppliers, destinations, pricing, and trade routes
Medcell Pharma exports 6 products worth $7.5M. Beyond Levofloxacin, top products include Ceftriaxone, Ofloxacin, Ondansetron, Amikacin, Nicotine. View the complete Medcell Pharma profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Levofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 1,543+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medcell Pharma's Levofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medcell Pharma
Full Company Profile →
6 products · $7.5M total trade · 4 categories
Access shipment-level records, pricing trends, and buyer contacts for Medcell Pharma.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Levofloxacin. For current shipment-level data, contact TransData Nexus.